2013•CancerRequires access

Tools to improve clinical trial design in urothelial cancer

Allison Mary Deal, Matthew I. Milowsky

Abstract

Two reports in this issue describe a nomogram for predicting survival and a landmark analysis demonstrating the relation between 6‐month and 9‐month progression‐free status and overall survival in patients with metastatic urothelial cancer. These 2 important tools will be used to improve future clinical trial design in patients with advanced urothelial cancer.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Urothelial cancer, Medicine, Nomogram, Clinical trial, Oncology, Cancer, Bladder cancer, Clinical study design